BAY-179
Selleck Chemicals
SKU:E1149-5MG
Couldn't load pickup availability
BAY-179 is an inhibitor of OXPHOS used in studies of pathway modulation. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to pathway-dependent signal amplification or attenuation in metabolism models. Dose-response comparison, orthogonal validation, and secondary assay follow-up can further sharpen mechanistic interpretation.
By inhibiting OXPHOS, BAY-179 can be used to examine pathway-dependent signal amplification or attenuation. This target class is commonly examined through pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping. In metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving OXPHOS
- Concentration-response inhibition and target-dependence studies
- Pathway-reporter and mechanistic-phenotyping studies
- Phenotypic profiling in metabolism models
Overall, BAY-179 is appropriate when a defined chemical perturbant is needed to connect OXPHOS with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- OXPHOS
- Target Class:
- Signaling Pathway Modulator
- Research Area:
- Metabolism
- CAS No.:
- 2764880-87-5
- Molecular Weight:
- 415.51
- Formula:
- C₂₃H₂₁N₅OS
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.